Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Pain and Headache Reports|July 7, 2017
LASH: A Review of the Current LiteratureWilliam Kingston, Rashmi HalkerCurrent Pain and Headache Reports|June 17, 2015
A Practical Approach to the Diagnosis of Spontaneous Intracranial HypotensionKristen Steenerson, Rashmi HalkerCurrent Pain and Headache Reports|May 31, 2020
Headache in the Older Population: Causes, Diagnoses, and TreatmentsJennifer Robblee, Rashmi Halker SinghSeminars in Neurology|March 31, 2010
Cluster headache: diagnosis and treatmentRashmi Halker, Bert Vargas, David W DodickCephalalgia : an International Journal of Headache|December 16, 2014
Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled studyEsma Dilli, Rashmi Halker, Bert Vargas, et al.The Journal of Headache and Pain|August 3, 2017
The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysisManjit Matharu, Rashmi Halker, Patricia Pozo-Rosich, et al.Neurology|October 11, 2013
Sensitivity of MRI of the spine compared with CT myelography in orthostatic headache with CSF leakAmaal Starling, Fatima Hernandez, Joseph M Hoxworth, et al.Headache|May 13, 2017
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered<sup>®</sup> Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral SumatriptanStephen Silberstein, Paul K Winner, Peter J McAllister, et al.Headache|May 22, 2021
Patient experience of telemedicine for headache care during the COVID-19 pandemic: An American Migraine Foundation survey studyChia-Chun Chiang, Rashmi Halker Singh, Nim Lalvani, et al.Headache|September 9, 2024
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraineJessica Ailani, Pranav Gandhi, Anjana Lalla, et al.Pageof 2